187 related articles for article (PubMed ID: 15634269)
1. Elevated levels of FVIII:C within families are associated with an increased risk for venous and arterial thrombosis.
Bank I; Libourel EJ; Middeldorp S; Hamulyák K; van Pampus EC; Koopman MM; Prins MH; van der Meer J; Büller HR
J Thromb Haemost; 2005 Jan; 3(1):79-84. PubMed ID: 15634269
[TBL] [Abstract][Full Text] [Related]
2. Absolute annual incidences of first events of venous thromboembolism and arterial vascular events in individuals with elevated FVIII:c. A prospective family cohort study.
Bank I; van de Poel MH; Coppens M; Hamulyák K; Prins MH; van der Meer J; Veeger NJ; Büller HR; Middeldorp S
Thromb Haemost; 2007 Nov; 98(5):1040-4. PubMed ID: 18000609
[TBL] [Abstract][Full Text] [Related]
3. Prothrombin 20210A mutation: a mild risk factor for venous thromboembolism but not for arterial thrombotic disease and pregnancy-related complications in a family study.
Bank I; Libourel EJ; Middeldorp S; Van Pampus EC; Koopman MM; Hamulyák K; Prins MH; Van Der Meer J; Büller HR
Arch Intern Med; 2004 Sep; 164(17):1932-7. PubMed ID: 15451770
[TBL] [Abstract][Full Text] [Related]
4. Familial clustering of high factor VIII levels in patients with venous thromboembolism.
Schambeck CM; Hinney K; Haubitz I; Mansouri Taleghani B; Wahler D; Keller F
Arterioscler Thromb Vasc Biol; 2001 Feb; 21(2):289-92. PubMed ID: 11156867
[TBL] [Abstract][Full Text] [Related]
5. High plasma levels of factor VIII and risk of recurrence of venous thromboembolism.
Cristina L; Benilde C; Michela C; Mirella F; Giuliana G; Gualtiero P
Br J Haematol; 2004 Feb; 124(4):504-10. PubMed ID: 14984502
[TBL] [Abstract][Full Text] [Related]
6. Beta-receptor blockade decreases elevated plasma levels of factor VIII:C in patients with deep vein thrombosis.
Hoppener MR; Kraaijenhagen RA; Hutten BA; Büller HR; Peters RJ; Levi M
J Thromb Haemost; 2004 Aug; 2(8):1316-20. PubMed ID: 15304037
[TBL] [Abstract][Full Text] [Related]
7. Elevated plasma factor VIII levels--a novel risk factor for venous thromboembolism.
O'Donnell J; Laffan M
Clin Lab; 2001; 47(1-2):1-6. PubMed ID: 11214218
[TBL] [Abstract][Full Text] [Related]
8. Protein S type III deficiency is no risk factor for venous and arterial thromboembolism in 168 thrombophilic families: a retrospective study.
Libourel EJ; Bank I; Veeger NJ; Hamulyàk K; Middeldorp S; Prins MH; Büller HR; van der Meer J
Blood Coagul Fibrinolysis; 2005 Mar; 16(2):135-40. PubMed ID: 15741801
[TBL] [Abstract][Full Text] [Related]
9. High levels of coagulation factors and venous thrombosis risk: strongest association for factor VIII and von Willebrand factor.
Rietveld IM; Lijfering WM; le Cessie S; Bos MHA; Rosendaal FR; Reitsma PH; Cannegieter SC
J Thromb Haemost; 2019 Jan; 17(1):99-109. PubMed ID: 30471183
[TBL] [Abstract][Full Text] [Related]
10. Elevated factor VIII is a risk factor for idiopathic venous thromboembolism in Canada - is it necessary to define a new upper reference range for factor VIII?
Wells PS; Langlois NJ; Webster MA; Jaffey J; Anderson JA
Thromb Haemost; 2005 May; 93(5):842-6. PubMed ID: 15886797
[TBL] [Abstract][Full Text] [Related]
11. The effect of beta-receptor blockade on factor VIII levels and thrombin generation in patients with venous thromboembolism.
Schönauer V; Giannini S; Christ G; Quehenberger P; Bieglmayer C; Stain M; Kyrle PA; Weltermann A
Thromb Haemost; 2003 May; 89(5):837-41. PubMed ID: 12719781
[TBL] [Abstract][Full Text] [Related]
12. High factor VIII levels contribute to the thrombotic risk in families with factor V Leiden.
Lensen R; Bertina RM; Vandenbroucke JP; Rosendaal FR
Br J Haematol; 2001 Aug; 114(2):380-6. PubMed ID: 11529860
[TBL] [Abstract][Full Text] [Related]
13. The risk of venous and arterial thrombosis in hyperhomocysteinemic subjects may be a result of elevated factor VIII levels.
Lijfering WM; Veeger NJ; Brouwer JL; van der Meer J
Haematologica; 2007 Dec; 92(12):1703-6. PubMed ID: 18055997
[TBL] [Abstract][Full Text] [Related]
14. Selective testing for thrombophilia in patients with first venous thrombosis: results from a retrospective family cohort study on absolute thrombotic risk for currently known thrombophilic defects in 2479 relatives.
Lijfering WM; Brouwer JL; Veeger NJ; Bank I; Coppens M; Middeldorp S; Hamulyák K; Prins MH; Büller HR; van der Meer J
Blood; 2009 May; 113(21):5314-22. PubMed ID: 19139080
[TBL] [Abstract][Full Text] [Related]
15. Marked elevation of thrombin generation in patients with elevated FVIII:C and venous thromboembolism.
O'Donnell J; Mumford AD; Manning RA; Laffan MA
Br J Haematol; 2001 Dec; 115(3):687-91. PubMed ID: 11736955
[TBL] [Abstract][Full Text] [Related]
16. Unselected women with elevated levels of factor VIII:C or homocysteine are not at increased risk for obstetric complications.
Middeldorp S; van de Poel MH; Bank I; Hamulyák K; Libourel EJ; Koopman MM; Prins MH; van der Meer J; Büller HR
Thromb Haemost; 2004 Oct; 92(4):787-90. PubMed ID: 15467909
[TBL] [Abstract][Full Text] [Related]
17. Low-density lipoprotein receptor-related protein polymorphisms in patients with elevated factor VIII coagulant activity and venous thrombosis.
Cunningham N; Laffan MA; Manning RA; O'Donnell JS
Blood Coagul Fibrinolysis; 2005 Oct; 16(7):465-8. PubMed ID: 16175004
[TBL] [Abstract][Full Text] [Related]
18. The risk of recurrent venous thromboembolism among patients with high factor IX levels.
Weltermann A; Eichinger S; Bialonczyk C; Minar E; Hirschl M; Quehenberger P; Schönauer V; Kyrle PA
J Thromb Haemost; 2003 Jan; 1(1):28-32. PubMed ID: 12871536
[TBL] [Abstract][Full Text] [Related]
19. Correlation between serum factor VIII:C levels and deep vein thrombosis following gynecological surgery.
Liu J; Sang C; Zhang Z; Jiang Y; Wang S; Li Y; Shi X
Bioengineered; 2021 Dec; 12(2):9668-9677. PubMed ID: 34845975
[TBL] [Abstract][Full Text] [Related]
20. Difference in absolute risk of venous and arterial thrombosis between familial protein S deficiency type I and type III. Results from a family cohort study to assess the clinical impact of a laboratory test-based classification.
Brouwer JL; Veeger NJ; van der Schaaf W; Kluin-Nelemans HC; van der Meer J
Br J Haematol; 2005 Mar; 128(5):703-10. PubMed ID: 15725093
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
